The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ErrataFull Access

Erratum

Published Online:https://doi.org/10.1176/pn.44.13.0003a

In the May 15 issue, the professional title of Fryderyka Shabry, M.D., was incorrect in the article titled “Psychiatry Resident Researchers Have Their Eyes on the Prize.” Her correct title is director of child and adolescent psychiatry at Coney Island Hospital in Brooklyn, N.Y.

In the June 5 issue, the article “FDA Reverses Earlier Decision, Approves Schizophrenia Drug” contained an error. The sentence concerning data comparing ziprasidone and risperidone should have read: “At press time, the company [Vanda Pharmaceuticals] had not released any data on how iloperidone compared with either ziprasidone or risperidone on efficacy indicators.” ▪